We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
+7.74%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.45B
AUM Growth
+$4.97M
(+0.2%)
Cap. Flow
-$96.9M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
39.08%
Holding
313
New
42
Increased
49
Reduced
96
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackstone
BX
|
+$61.1M |
| 2 |
Toll Brothers
TOL
|
+$20.7M |
| 3 |
Home Depot
HD
|
+$19.5M |
| 4 |
Starbucks
SBUX
|
+$18.8M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$49.7M |
| 2 |
Stryker
SYK
|
+$42M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$23.1M |
| 4 |
NVIDIA
NVDA
|
+$21.1M |
| 5 |
SLB Ltd
SLB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 12.67% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 11.03% |
| 5 | Industrials | 8.63% |
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q3 2024 Portfolio in Review
As of Q3 2024, Castleark Management held 313 positions worth $2.45B, up 0.2% from $2.45B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Castleark Management withdrew a net $96.9M in Q3 2024, closing 41 positions and reducing 96 holdings. Its most notable exit was DexCom, an estimated $49.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Blackstone worth $67.5M.
- Castleark Management's largest Q3 2024 buy was Blackstone: 440,620 shares worth $67.5M.
- Castleark Management added most to Home Depot in Q3 2024, an estimated $19.5M increase.
- Castleark Management's biggest Q3 2024 reduction was Stryker, cutting an estimated $42M.
- Castleark Management fully exited DexCom in Q3 2024, selling an estimated $49.7M.
- Castleark Management's ten largest holdings make up 39% of its $2.45B portfolio in Q3 2024.
- Castleark Management opened 42 new positions and closed 41 in Q3 2024.
- Castleark Management's portfolio value rose 0.2% quarter-over-quarter to $2.45B.
Based on Castleark Management's 13F filing for Q3 2024, filed 15 Nov 2024.